311 related articles for article (PubMed ID: 32595456)
1. Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein.
Guan Y; Zhao X; Liu F; Yan S; Wang Y; Du C; Cui X; Li R; Zhang CX
Front Cell Neurosci; 2020; 14():159. PubMed ID: 32595456
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice.
Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI
Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344
[TBL] [Abstract][Full Text] [Related]
3. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596
[TBL] [Abstract][Full Text] [Related]
4. "Janus-Faced" α-Synuclein: Role in Parkinson's Disease.
Ray B; Mahalakshmi AM; Tuladhar S; Bhat A; Srinivasan A; Pellegrino C; Kannan A; Bolla SR; Chidambaram SB; Sakharkar MK
Front Cell Dev Biol; 2021; 9():673395. PubMed ID: 34124057
[TBL] [Abstract][Full Text] [Related]
5. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
Rutherford NJ; Moore BD; Golde TE; Giasson BI
J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
[TBL] [Abstract][Full Text] [Related]
6. Change in the Oligomeric State of α-Synuclein Variants in Living Cells.
Fan HF; Chen WL; Chen YZ; Huang JW; Shen YX
ACS Chem Neurosci; 2022 Apr; 13(8):1143-1164. PubMed ID: 35394271
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 modifies α-syn pathology and spread in mouse models and human neurons.
Bieri G; Brahic M; Bousset L; Couthouis J; Kramer NJ; Ma R; Nakayama L; Monbureau M; Defensor E; Schüle B; Shamloo M; Melki R; Gitler AD
Acta Neuropathol; 2019 Jun; 137(6):961-980. PubMed ID: 30927072
[TBL] [Abstract][Full Text] [Related]
8. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.
Sanjeev A; Mattaparthi VSK
J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719
[TBL] [Abstract][Full Text] [Related]
9. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
[TBL] [Abstract][Full Text] [Related]
10. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
[TBL] [Abstract][Full Text] [Related]
11. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
[TBL] [Abstract][Full Text] [Related]
12. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and morphological classification of disease-associated alpha-synuclein mutants aggregates.
Tanaka G; Yamanaka T; Furukawa Y; Kajimura N; Mitsuoka K; Nukina N
Biochem Biophys Res Commun; 2019 Jan; 508(3):729-734. PubMed ID: 30528390
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models.
Petrucci S; Ginevrino M; Valente EM
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S16-20. PubMed ID: 26341711
[TBL] [Abstract][Full Text] [Related]
15. Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface.
Sun C; Zhou K; DePaola P; Shin WS; Hillyer T; Sawaya MR; Zhu R; Peng C; Zhou ZH; Jiang L
J Biol Chem; 2023 Apr; 299(4):104566. PubMed ID: 36871760
[TBL] [Abstract][Full Text] [Related]
16. The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.
Fares MB; Ait-Bouziad N; Dikiy I; Mbefo MK; Jovičić A; Kiely A; Holton JL; Lee SJ; Gitler AD; Eliezer D; Lashuel HA
Hum Mol Genet; 2014 Sep; 23(17):4491-509. PubMed ID: 24728187
[TBL] [Abstract][Full Text] [Related]
17. Limited spread of pathology within the brainstem of α-synuclein BAC transgenic mice inoculated with preformed fibrils into the gastrointestinal tract.
Uemura N; Yagi H; Uemura MT; Yamakado H; Takahashi R
Neurosci Lett; 2020 Jan; 716():134651. PubMed ID: 31783082
[TBL] [Abstract][Full Text] [Related]
18. The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity.
Khalaf O; Fauvet B; Oueslati A; Dikiy I; Mahul-Mellier AL; Ruggeri FS; Mbefo MK; Vercruysse F; Dietler G; Lee SJ; Eliezer D; Lashuel HA
J Biol Chem; 2014 Aug; 289(32):21856-76. PubMed ID: 24936070
[TBL] [Abstract][Full Text] [Related]
19. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy.
Li Y; Zhao C; Luo F; Liu Z; Gui X; Luo Z; Zhang X; Li D; Liu C; Li X
Cell Res; 2018 Sep; 28(9):897-903. PubMed ID: 30065316
[TBL] [Abstract][Full Text] [Related]
20. Label-free detection of early oligomerization of α-synuclein and its mutants A30P/E46K through solid-state nanopores.
Li X; Tong X; Lu W; Yu D; Diao J; Zhao Q
Nanoscale; 2019 Mar; 11(13):6480-6488. PubMed ID: 30892349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
